<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
<head>
    <meta charset="utf-8" />
<script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","https://www.google-analytics.com/analytics.js","ga");ga("create", "UA-2231938-8", {"cookieDomain":"auto"});ga("require", "linkid", "linkid.js");ga("set", "anonymizeIp", true);ga("send", "pageview");</script>
<meta name="Generator" content="Drupal 8 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Merriweather:300|Lato:italic,700|Josefin+Sans:700,300&amp;subset=latin,latin-ext" media="all" />
<link rel="shortcut icon" href="/insureintell-1col/core/misc/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="canonical" href="https://rtaylor193.github.io/insureintell-1col/node/25655" />
<link rel="shortlink" href="https://rtaylor193.github.io/insureintell-1col/node/25655" />
<link rel="revision" href="https://rtaylor193.github.io/insureintell-1col/node/25655" />

        <title>Cutaneous Lupus Erythematosus | Insureintell.com</title>
        <link rel="stylesheet" media="all" href="/insureintell-1col/sites/default/files/css/css_0cn0wRaOkAvoXa-_4l1dms-M-hBepIrzQH8XMAQJVwg.css" />
<link rel="stylesheet" media="all" href="/insureintell-1col/sites/default/files/css/css_1g_7Rhof1xPNoR5sXcW2q6l4KX3RXBNPK2sTAkysEdQ.css" />

            
<!--[if lte IE 8]>
<script src="/insureintell-1col/sites/default/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->

     <link href='//fonts.googleapis.com/css?family=Raleway:400,300,600' rel='stylesheet' type='text/css'>

                  </head>
<body class="fontyourface path-node node--type-article">
<a href="#main-content" class="visually-hidden focusable skip-link">
    Skip to main content
</a>

  <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    
<div id="page-wrapper">
    <div id="page">
        <header id="header" class="header" role="banner" aria-label="Site header">
            <div class="section clearfix">
                
                <div class="no-mobile">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
</div>
                <nav id="navigation" class="navbar replaceme menu original">
                <div class="menu-header">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
 &nbsp; <div id="nav-icon"><span></span><span></span><span></span><span></span><span></span><span></span></div></div>
                    <div class="container">
                    
                    </div>
                </nav>
            </div>
        </header>
                    <div class="highlighted">
                <aside class="section clearfix" role="complementary">
                      <div>
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>

                </aside>
            </div>
                        <div id="main-wrapper" class=" clearfix">
            <div id="main" class="clearfix">
                
                                                    <section class="section">
                        <a id="main-content" tabindex="-1"></a>
                                                                            
                        <div class="ten">
                              <div>
    <div id="block-light-skeleton-page-title--4" class="block block-core block-page-title-block">
    
        
            <div class="content">
            
<div class="sixteen page-title container floated ">
    <h1 class="title_page" ><span property="schema:name">Cutaneous Lupus Erythematosus</span>
</h2>
</div>


        </div>
    </div>
<section class="page-content container floated ">
<div data-history-node-id="25655" class="node node--type-article node--view-mode-full ds-3col-stacked-equal clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div>Submitted by <a title="View user profile." href="/insureintell-1col/user/6" lang="" about="/insureintell-1col/user/6" typeof="schema:Person" property="schema:name" datatype="">hankgeorge</a> on Thursday, May 1, 2008 - 05:00.</div>
      
            <div property="schema:text"><p><strong>Note to Readers</strong></p>

<p>This article supplements the content of our 2007 CE course on systemic lupus (SLE), where we did not have enough room to address this important topic.</p>

<p>&nbsp;</p>

<p><strong>Why is this subject worth reading about?</strong></p>

<p>Most underwriters know a great deal more about SLE (systemic lupus erythematosus) than they do about “skin lupus.”</p>

<p>The intention of this article is to raise awareness of the underwriting issues in the main forms of skin lupus.</p>
<!--break--><!--break-->

<p><strong>Is it fair to say that skin lupus and systemic lupus are the same disease?</strong></p>

<p>Yes – the lupus is just manifesting differently.</p>

<p>Some patients get skin disease only, whereas others get both.</p>

<p>The “why” of this fact remains to be definitively established. [Bano]</p>

<p><strong>What are the 3 main types of cutaneous (skin) lupus?</strong></p>

<ul>
	<li>Chronic cutaneous lupus erythematosus (CCLE), of which the only type encountered more<br />
	than rarely is discoid lupus erythematosus (DLE)</li>
	<li>Subacute cutaneous lupus erythematosus (SCLE)</li>
	<li>Acute cutaneous lupus erythematosus (ACLE)</li>
</ul>

<p><strong>Does cutaneous lupus always mean skin only? </strong></p>

<blockquote>
<p><em>“The term cutaneous lupus erythematosus is applied to patients with skin lesions caused by lupus erythematosus, regardless of whether the disease is confined to the skin or represents part of a more generalized systemic disease process.”</em></p>

<blockquote>
<p>Dimitrios T. Boumpas, MD, et al.<br />
<br />
<em>Annals of Internal Medicine</em><br />
<br />
123(1995):42</p>
</blockquote>
</blockquote>

<p>In other words, just being told it is “cutaneous” or “skin” lupus, without knowing the precise type, can mislead one into thinking a case of SLE with skin involvement is a case of skin lupus only!</p>

<p><em>Know the precise type every time!</em></p>

<p><strong>How common is skin involvement in systemic lupus (SLE)?</strong> [Bano]</p>

<ul>
	<li>58% have a malar (butterfly) rash – more on this later</li>
	<li>45% have photosensitivity (adverse response to direct sunlight)</li>
	<li>10% will have “discoid lesions”</li>
	<li>6% will have subacute cutaneous LE (SCLE)</li>
</ul>

<p><strong>When does skin lupus typically arise?</strong></p>

<p>Ages 20-40, but it can arise at any age. [Tebbe]</p>

<p><strong>Is it more common in women?</strong></p>

<p>Yes, roughly 3-4:1 in DLE (discoid) and 3-6:1 in SCLE. [Hackett, Tebbe]</p>

<p><strong>What can trigger the onset of skin lupus? [Rothfield] </strong></p>

<ul>
	<li>Exposure to sunlight, cold and x-ray radiation</li>
	<li>Trauma to the skin</li>
	<li>Skin infection</li>
	<li>Chemical burns</li>
	<li>Various kinds of dermatitis</li>
	<li>Scars</li>
</ul>

<p><strong>Is it significant when a proposed insured tells us he/she must wear sunblock and/or minimize sunlight exposure in some other manner on a regular basis? </strong></p>

<p>Absolutely.</p>

<p>Lupus is just one of a number of possible reasons with underwriting implications. This comment always needs to be pursued.</p>

<p><strong>How is sun protection achieved in all cases of lupus?</strong></p>

<ul>
	<li>Avoid direct sun exposure</li>
	<li>Sunscreens of higher potency</li>
	<li>Tightly woven clothing, broad-brimmed hats</li>
</ul>

<p><strong>Is failure to adhere to these recommendations significant?</strong></p>

<p>Yes, for two reasons:</p>

<ul>
	<li>It will usually result in exacerbations/worsening of skin lesions.</li>
	<li>It speaks to a deeper issue of risk-taking in the form of non-adherence to medical recommendations, which many feel is a marker for other adverse behaviors…and there is plenty of evidence now to support this belief!</li>
</ul>

<p><strong>In what two ways has the term “discoid lupus” come to be used clinically?</strong></p>

<ol>
	<li>To designate a subset of persons with skin disease only and no significant evidence of systemic involvement (which is how we tend to use the term).</li>
	<li>To refer generically to a number of distinctive skin lesions in SLE (which, for the record, are<br />
	rarely associated with aggressive forms of SLE).</li>
</ol>

<p>On balance, when the term “discoid lupus” is used, the other facts disclosed should be consistent with DLE… and NOT with SCLE, ACLE or overt SLE.</p>

<p><strong>Where do discoid skin lesions usually occur?</strong></p>

<ul>
	<li>They can occur anywhere but most involve the scalp, face and/or ears.</li>
	<li>Scalp lesions occur in 60% and can be the only presentation in 10%.</li>
	<li>The V-region of the neck is also involved in a minority of cases.</li>
	<li>Mucosal DLE is uncommon; it may involve the mouth, nasal passages, conjunctiva and even genital mucosa. [Rothfield]</li>
	<li>Lesions below the neck are distinctly uncommon and most that do occur are on the extensor surfaces of the arms.</li>
	<li>When other lesions below the neck are present, the diagnosis of DLE should be questioned unless it is clearly established by biopsy.</li>
	<li>Patients with lesions below the neck will sometimes be said to have “widespread DLE.” [Callen, 2005]</li>
</ul>

<p><strong>Is the “butterfly rash” a feature of DLE? </strong></p>

<p>No – this is a RED FLAG for ACLE and systemic disease.</p>

<p><strong>Is cigarette smoking a risk factor for SLE? </strong></p>

<p>Big time! [Miot]</p>

<ul>
	<li>The risk is almost 3-fold higher</li>
	<li>Cumulative past exposure is less of an issue than current use</li>
	<li>Smokers tend to have more extensive disease at onset</li>
</ul>

<p><strong>Do DLE patients ever have positive lupus-related autoantibody tests? </strong></p>

<p>Most cases do not have a positive ANA or, if they do, only a minimally increased titer in the range of 1:40. [Sontheimer, 1997]</p>

<p>Any time the titer is higher or other autoantibodies are present, question the presumed diagnosis of DLE – <strong><em>it is probably wrong! </em></strong></p>

<p><strong>Is a biopsy always needed to diagnose DLE? </strong></p>

<p>No…but it is the only way to absolutely confirm the Dx and rule out other possible causes of the suspicious lesion. [Callen, 2006]</p>

<p><strong>What % with ostensible DLE progress to SLE? </strong></p>

<p>&lt; 7%, and most of these will be misdiagnosed cases of SCLE and/or have multiple persistent laboratory abnormalities. [Millard]</p>

<p><strong>What is the classic lesion of acute cutaneous lupus erythematosus (ACLE)?</strong></p>

<p>The “butterfly rash.” [Callen, 2005]</p>

<p><strong>Is ACLE usually associated with systemic disease? </strong></p>

<p>Yes – and more often than not, relatively severe systemic disease! [Cullen, 2006]</p>

<p><strong>How does subacute cutaneous lupus erythematosus (SCLE) differ from SLE and ACLE? </strong></p>

<p>It is more extensive than SLE, typically involving the upper back and usually spares the upper neck and face.</p>

<p>SCLE patients have chronically recurring skin disease and also often have arthralgias, malaise and other generalized symptoms which do not occur in SLE.</p>

<p>10% of SCLE patients have central nervous system and renal disease, and for all intents and purposes represent severe systemic disease.</p>

<p><strong>Is SCLE more likely to have positive autoantibody tests than DLE?</strong></p>

<p>Yes, significantly so, with 80% having an ANA positive with titer of 1:160 or higher (which is in the SLE range). Other autoantibodies associated with systemic disease are also frequently found as well. [Sontheimer, 1985]</p>

<p><strong>Does Rx cause SCLE? </strong></p>

<p>Yes, there is a huge list of drugs which can induce SCLE. None do so more than rarely.</p>

<p><strong><em>ACLE and SCLE must never be confused with DLE </em></strong><em>– this is one of the two main issues involved in underwriting skin lupus, the other being to rule out systemic disease (SLE). </em></p>

<p><strong>Why is skin lupus treated?</strong></p>

<ul>
	<li>To improve the patient’s physical appearance</li>
	<li>To prevent scarring, skin atrophy or pigmentation changes</li>
</ul>

<p><strong>How are most cases of DLE treated? </strong></p>

<ul>
	<li>Topic hydrocortisone.</li>
	<li>Intralesional injection of a steroid in very localized DLE.</li>
	<li>If these do not work, hydroxychloroquine. However, hydroxychloroquine may also be used in the other forms of skin lupus as well as in SLE.</li>
</ul>

<p><strong>What other drugs are used to treat more severe DLE as well as SCLE? </strong></p>

<ul>
	<li>Retinoids such as isotretinoin.</li>
	<li>Tacrolimus and pimecrolimus.</li>
	<li>Thalidomide – which may be the best drug for severe cases of skin lupus; it is also used in<br />
	SLE. [Cuadrado]</li>
	<li>Chloroquine and quinacrine.</li>
	<li>When immunosuppressives, biological agents and other SLE drugs are prescribed, you<br />
	can safely bet that systemic disease is present.</li>
</ul>

<p><strong>Do most patients with DLE get a remission?</strong></p>

<p>If they have only head and neck disease, yes, at least 50% remit, often without recurrence of obvious/active skin lesions for many years, even decades.</p>

<p>However, if the disease is more widespread, then &lt; 10% become clinically inactive despite Rx. [Callen, 2006]</p>

<p><strong>Is there any extra mortality in DLE? </strong></p>

<blockquote>
<p><em>“Discoid lupus is a chronic indolent skin disorder with no significant extra mortality.” </em></p>

<blockquote>
<p>David S. Williams, MD<br />
<br />
Ohio National Financial Services<br />
<br />
<em>Journal of Insurance Medicine </em><br />
<br />
37(2005):70</p>
</blockquote>
</blockquote>

<p><strong>What is the mortality issue in DLE? </strong></p>

<p>Making certain it is discoid only…as opposed to SCLE, ACLE or DLE.</p>

<p><strong>A</strong><strong>re there disability implications in DLE?</strong></p>

<p>In a German study, 45% of patients with DLE experienced “vocational handicaps,” although one would think that in those with less extensive disease this would be minimal, except perhaps in some public contact jobs. [Meller]</p>

<p><strong>Are treatment costs higher in SLE than in DLE?</strong></p>

<p>Absolutely.</p>

<p>SLE treatment cost 12-fold more dollars in one study, once the clinical workup is done and SLE is ruled out.</p>

<p>Most of the medication used in DLE is topical and relatively cheap, compared to other drugs used in SLE.</p>

<p>Inpatient care is rare (&lt; 3%) in DLE. Periodic visits to a community dermatologist constitute most of the care after the diagnosis is made. [Hackett]</p>

<p><strong>Is there a “WORST CASE” for DLE? </strong></p>

<p>Not really (at least for mortality). However, there are scenarios which need to be carefully<br />
underwritten:</p>

<ul>
	<li>Diagnosis is uncertain, especially if disease is more extensive than just on the face, scalp and/or ears (raising a question of misdiagnosis of SCLE).</li>
	<li>Inadequate autoantibody testing, defined as not having at least an ANA test.</li>
	<li>Persistently positive ANA ≥1:50 with a speckled or homogeneous immunofluorescent pattern. [Millard]</li>
	<li>Presence of leukopenia or thrombocytopenia not otherwise explained.</li>
	<li>With symptoms or other findings associated with systemic disease.</li>
</ul>

<p><strong>What about the other kinds of skin lupus? </strong></p>

<ul>
	<li>ACLE should be assumed to be associated (either concurrently or eventually) with a diagnosis of systemic disease.</li>
	<li>SCLE has a considerable risk of progressing to systemic disease.</li>
	<li>One would think SCLE rarely acceptable “standard” (unless it has been confined to the skin for many years with consistently favorable autoantibody tests).</li>
</ul>

<p><strong>Do DLE and SLE ever arise at the same time? </strong></p>

<p>Yes, rarely…and when they do, most studies show that the SLE tends to be rather mild, without lethal renal disease. [Callen, 2005]</p>

<p>&nbsp;</p>

<p><strong>References</strong></p>

<p>Bano. <em>Clinical and Experimental Rheumatology.</em> 24, Supplement 40(2006):S26<br />
Callen, 2005. <em>Best Practice and Research Clinical Rheumatology.</em> 19(2005):767<br />
Callen, 2006. <em>Australian Journal of Dermatology.</em> 47(2006):13<br />
Cuadrado. <em>American Journal of Medicine.</em> 177(2005):246<br />
Hackett. <em>Arthritis &amp; Rheumatism. </em>52, Supplement(September, 2005):S36<br />
Meller. <em>Autoimmune Review.</em> 4(2005):242<br />
Millard. <em>Archives of Dermatology.</em> 115(1979):1055<br />
Miot. <em>Dermatology.</em> 211(2006):118<br />
Rothfield. <em>Clinics in Dermatology. </em>24(2006):348<br />
Sontheimer, 1977. <em>Lupus.</em> 6(1997):84<br />
Sontheimer, 1985. <em>The Journal of Dermatology. </em>12(1985):20</p>
</div>
      
  </div>

  <div class="group-left">
    
  </div>

  <div class="group-middle">
    
  </div>

  <div class="group-right">
    
  </div>

  <div class="group-footer">
    
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/408" property="schema:about" hreflang="en">cutaneous lupus erythematosus (CLE)</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/27" property="schema:about" hreflang="en">Medical Underwriting</a></div>
          </div>
  
  </div>

</div>


</section>



  </div>

                        </div>
                    </section>
                                            </div>
        </div>
        <div class="clearfix"></div>
        <footer class="site-footer">
            <div class="layout-container">
                                                    <div class="site-footer__bottom container page_footer">
                          <div>
    <div id="block-foot-3" class="block block-block-content block-block-content084078bf-6f39-47ba-bdb3-8d97b34316a4">
    
        
            <div class="content">
            
            <div><footer class="text-align-center">
<h5>Insureintell.com is an independent publication designed to provide business information and opinion to life and health insurance underwriters. It is intended to encourage discussion and further research.<br />
Insureintell.com does not recommend any specific action or risk appraisal in any individual life or health insurance application. All information and opinion published should undergo formal scrutiny by underwriting officers, medical directors, actuaries, legal counsel and other insurance professionals as appropriate.</h5>

<h5>Copyright® 2019&nbsp;Hank George, Inc. All Rights Reserved.</h5>
</footer>
</div>
      
        </div>
    </div>

  </div>

                    </div>
                            </div>
        </footer>
    </div>
</div>
  </div>

<div class="region region-page-bottom"><div id="fancy_login_dim_screen"></div><div id="fancy_login_login_box"><div id="fancy_login_form_contents"><a href="#" id="fancy_login_close_button">X</a><div id="fancy_login_user_login_block_wrapper"><form class="fancy-login-user-login-form" data-drupal-selector="fancy-login-user-login-form-4" action="/insureintell-1col/node/25655" method="post" id="fancy-login-user-login-form--4" accept-charset="UTF-8">
  <div class="js-form-item form-item js-form-type-textfield form-item-name js-form-item-name">
      <label for="edit-name--4" class="js-form-required form-required">Username</label>
        <input autocorrect="none" autocapitalize="none" spellcheck="false" data-drupal-selector="edit-name" type="text" id="edit-name--4" name="name" value="" size="15" maxlength="60" class="form-text required" required="required" aria-required="true" />

        </div>
<div class="js-form-item form-item js-form-type-password form-item-pass js-form-item-pass">
      <label for="edit-pass--4" class="js-form-required form-required">Password</label>
        <input data-drupal-selector="edit-pass" type="password" id="edit-pass--4" name="pass" size="15" maxlength="128" class="form-text required" required="required" aria-required="true" />

        </div>
<input autocomplete="off" data-drupal-selector="form-pxaesypcmbva95fkppqd4g234vioti-rg3jc-2elg-8" type="hidden" name="form_build_id" value="form-PxaEsYPcmbvA95fKppqD4g234ViOTI-RG3JC_2Elg_8" />
<input data-drupal-selector="edit-fancy-login-user-login-form-4" type="hidden" name="form_id" value="fancy_login_user_login_form" />
<ul data-drupal-selector="edit-user-links"><li><a href="/insureintell-1col/user/password" title="Request new password via email.">Request new password</a></li></ul><div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--4"><input data-drupal-selector="edit-submit-1592925733" type="submit" id="edit-submit-1592925733--4" name="op" value="Log in" class="button js-form-submit form-submit" />
</div>

</form>
</div></div></div></div>
<script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/insureintell-1col\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/25655","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"core\/drupal.ajax,core\/html5shiv,core\/jquery.form,ds\/ds_3col_stacked_equal_width,extlink\/drupal.extlink,fancy_login\/popup,fontyourface\/font_display_light_skeleton,google_analytics\/google_analytics,light_skeleton\/skeleton,statistics\/drupal.statistics,system\/base","theme":"light_skeleton","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true,"\/insureintell-1col\/node\/25655?ajax_form=1":true},"fancyLogin":{"screenFadeColor":"grey","screenFadeZIndex":10,"loginBoxBackgroundColor":"white","loginBoxTextColor":"black","loginBoxBorderColor":"black","loginBoxBorderWidth":"1px","loginBoxBorderStyle":"solid","loginPath":"\/user\/login","dimFadeSpeed":null,"boxFadeSpeed":null,"hideObjects":false},"ajax":{"edit-submit-1592925733--4":{"callback":"fancy_login_user_login_block_ajax_callback","event":"mousedown","keypress":true,"prevent":"click","url":"\/insureintell-1col\/node\/25655?ajax_form=1","dialogType":"ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Log in"}}},"google_analytics":{"trackOutbound":true,"trackMailto":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":null,"extNofollow":null,"extFollowNoOverride":null,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"","mailtoClass":"0","mailtoLabel":"(link sends email)"}},"statistics":{"data":{"nid":"25655"},"url":"\/insureintell-1col\/core\/modules\/statistics\/statistics.php"},"user":{"uid":0,"permissionsHash":"9eefd52671687a581488e58f9810121b71f4049b340084fc527a3c9edd844181"}}</script>
<script src="/insureintell-1col/sites/default/files/js/js_oQYRUFqxDC8yo8Px51wLXC2fMQ61-iVU0WrSI8DgY-w.js"></script>

</body>
</html>
